Cutaneous Eruptions Associated With Androgen Receptor Inhibitors for Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Ahmad, Ihtisham [1 ]
Sood, Siddhartha [1 ]
Al-Daqqaq, Zizo [1 ]
Bagit, Ahmed [1 ]
Maliyar, Khalad [2 ]
Mufti, Asfandyar [2 ,3 ]
Yeung, Jensen [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[4] Womens Coll Hosp, Dept Dermatol, Toronto, ON, Canada
[5] Prob Med Res, Waterloo, ON, Canada
[6] Womens Coll Hosp, Div Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2024年 / 28卷 / 04期
关键词：
cutaneous eruption; meta-analysis; prostate cancer; androgen receptor inhibitor; adverse event; drug eruption;
D O I：
10.1177/12034754241239278
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [21] Meta-analysis of efficacy and safety of custirsen in patients with metastatic castration-resistant prostate cancer
    Zhang, Xuebao
    Liu, Chu
    Li, Kui
    Wang, Ke
    Zhang, Qiqiang
    Cui, Yuanshan
    MEDICINE, 2019, 98 (06)
  • [22] Efficacy and toxicity of molecular targeted therapies in combination with docetaxel for metastatic castration-resistant prostate cancer: a meta-analysis of phase III randomized controlled trials
    Qi, Wei-Xiang
    Fu, Shen
    Zhang, Qing
    Guo, Xiao-Mao
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (03) : 181 - 187
  • [23] Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials
    Liu, Yang
    Deng, Xianzhong
    Wen, Zhi
    Huang, Jing
    Wang, Chongjian
    Chen, Caixia
    Bao, Erhao
    Wang, Jiahao
    Yang, Xuesong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
    Russo, Joshua W.
    Liu, Xiaming
    Ye, Huihui
    Calagua, Carla
    Chen, Sen
    Voznesensky, Olga
    Condulis, James
    Ma, Fen
    Taplin, Mary-Ellen
    Einstein, David J.
    Balk, Steven P.
    Chen, Shaoyong
    CANCER LETTERS, 2018, 438 : 97 - 104
  • [25] Treatment of Metastatic, Castration-Resistant, Docetaxel-Resistant Prostate Cancer: A Systematic Review of Literature With a Network Meta-Analysis of Randomized Clinical Trials
    Tassinari, Davide
    Cherubini, Chiara
    Roudnas, Britt
    Tamburini, Emiliano
    Drudi, Fabrizio
    Bianchi, Emanuela
    Fantini, Manuela
    Montanari, Francesco
    Sartori, Sergio
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 226 - 237
  • [26] Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Wu, Kan
    Liang, Jiayu
    Shao, Yanxiang
    Xiong, Sanchao
    Feng, Shuyang
    Li, Xiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] Efficacy and Safety of Combination AKT and Androgen Receptor Signaling Inhibition in Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis
    Nahar, Tulika A. K.
    Bantounou, Maria Anna
    Savin, Isabella
    Chohan, Nakul
    Kumar, Niraj S.
    Ghose, Aruni
    Mcewan, Ian J.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [28] Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
    Shiota, Masaki
    Yokomizo, Akira
    Fujimoto, Naohiro
    Naito, Seiji
    CURRENT CANCER DRUG TARGETS, 2011, 11 (07): : 870 - 881
  • [29] Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysis
    Roumiguie, Mathieu
    Paoletti, Xavier
    Neuzillet, Yann
    Mathieu, Romain
    Vincendeau, Sebastien
    Kleinclauss, Francois
    Mejean, Arnaud
    Guy, Laurent
    Timsit, Marc Olivier
    Lebret, Thierry
    FUTURE ONCOLOGY, 2021, 17 (14) : 1811 - 1823
  • [30] Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
    Lavaud, Pernelle
    Dumont, Clement
    Thibault, Constance
    Albiges, Laurence
    Baciarello, Giulia
    Colomba, Emeline
    Flippot, Ronan
    Fuerea, Alina
    Loriot, Yohann
    Fizazi, Karim
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345